Search - tctmd.com

Displaying 241 - 260 of 291

Sort: Relevancy | Date

Presentation TCT 2014

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

Presenter: Markus Kasel, Joachim Schofer

September 13, 2014

Presentation TCT 2014

TCT 691: Clinical Impact of the Presence of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation

Presenter: Valentin Fuster, Marina Urena, MD

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

Presentation TCT 2013

Post-Procedural Aortic Regurgitation in Balloon-expandable and Self-expandable TAVR Procedures: Analysis of Predictors and Impact on Long-term Mortality - Insights from the...

Presenter: Eric Van Belle

October 31, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

Presentation TCT 2013

Case #1: Off-Label Transcatheter Valve Implantation In Aortic Regurgitation

Presenter: Julia Jorgova

October 30, 2013

Presentation TCT 2013

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Presenter: Andreas R?ck

October 29, 2013

Presentation TCT 2013

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Baris Bugan

October 29, 2013

Presentation TCT 2013

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Presenter: Leo Marcoff

October 29, 2013

Presentation TCT 2013

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Presenter: Jae Oh

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Reduces Paravalvular Regurgitation

Presenter: Rebecca Hahn

October 28, 2013

Presentation TCT 2013

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR

Presenter: Samir Kapadia

October 28, 2013

Presentation TCT 2013

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Presenter: Hans Figulla

October 28, 2013

Presentation TCT 2013

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Jonathon Leipsic

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

Advertisement

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

TCT 691: Clinical Impact of the Presence of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Post-Procedural Aortic Regurgitation in Balloon-expandable and Self-expandable TAVR Procedures: Analysis of Predictors and Impact on Long-term Mortality - Insights from the...

Second-Generation TAVR Device Overcomes Issues of Current Valves

Case #1: Off-Label Transcatheter Valve Implantation In Aortic Regurgitation

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve...

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Opportunities Exist to Improve Outcomes in Transapical TAVR

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Reduces Paravalvular Regurgitation

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content